TLC BioSciences Corp. (TPEX: 7924)
Health Care · Biotechnology · TW
NT$375.00
-2.47% today · +78.1% 1Y
Public summary
A free snapshot of TLC BioSciences Corp., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app TLC BioSciences Corp. (TPEX: 7924) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.52B.
Over the last twelve months the share price has gained 78.1%, trading between 163.00 and 503.00.
Tweenvest scores TLC BioSciences Corp. across four factors: quality 18/100, value 67/100. Its strongest factor is value.
7924 price history
Key figures
- Market cap
- $1.52B
- Revenue (TTM)
- $2.47M
- P/E
- -22.33
- EPS
- -7.84
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- NT$503.00
- 52-week low
- NT$163.00
- Avg volume (3M)
- —
- Shares outstanding
- 133.56M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Nanjing Vazyme Biotech Co., LtdSHSE: 688105 | $1.54B | CN¥19.89 | -3.82% |
| Mesoblast LimitedASX: MSB | $1.53B | AU$1.76 | -1.95% |
| Vitrolife AB (publ)OM: VITR | $1.53B | Skr117.40 | -0.25% |
| Kailera Therapeutics, Inc.NasdaqGS: KLRA | $1.53B | $11.79 | -3.36% |
| Zhuhai Trinomab Pharmaceutical Co., Ltd.SHSE: 688806 | $1.52B | CN¥21.97 | -5.02% |
| Voronoi, Inc.KOSDAQ: A310210 | $1.51B | ₩111,000.00 | +1.19% |
| CanSino Biologics Inc.SEHK: 6185 | $1.50B | HK$23.34 | -1.85% |
| AlvotechNasdaqGM: ALVO | $1.50B | $4.19 | -10.28% |